APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Infective Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-Infective Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchAnti-Infective Vaccines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Infective Vaccines Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-Infective Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Infective Vaccines Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Infective Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Anti-Infective Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-Infective Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Infective Vaccines include Sanofi Pasteur, Novartis Vaccines, Merck & Co., GlaxoSmithKline Biologicals, Wyeth Pharmaceuticals, Inc., Protein Sciences Co., Organon Teknika Co., MedImmune LLC and MassBiologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-Infective Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Infective Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Infective Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Infective Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-Infective Vaccines Segment by Company

Sanofi Pasteur

Novartis Vaccines

Merck & Co.

GlaxoSmithKline Biologicals

Wyeth Pharmaceuticals, Inc.

Protein Sciences Co.

Organon Teknika Co.

MedImmune LLC

MassBiologics

Intercell Biomedical

ID Biomedical Co.

Emergent BioDefense Operations Lansing Inc.

Diagnostics Ltd.

CSL Ltd.

Berna Biotech

Barr Labs, Inc.

Anti-Infective Vaccines Segment by Type

Inactivated Vaccines

Live/attenuated Vaccines

Conjugate Vaccines

Anti-Infective Vaccines Segment by Application

Bacterial Diseases

Viral Diseases

Anti-Infective Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infective Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Infective Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infective Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-Infective Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Infective Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-Infective Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-Infective Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-Infective Vaccines Industry Trends Table 2. Anti-Infective Vaccines Industry Drivers Table 3. Anti-Infective Vaccines Industry Opportunities and Challenges Table 4. Anti-Infective Vaccines Industry Restraints Table 5. Global Anti-Infective Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-Infective Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Anti-Infective Vaccines Sales Market Share by Manufacturers Table 9. Global Anti-Infective Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Anti-Infective Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-Infective Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-Infective Vaccines Manufacturers, Product Type & Application Table 13. Global Anti-Infective Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-Infective Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Inactivated Vaccines Table 17. Major Manufacturers of Live/attenuated Vaccines Table 18. Major Manufacturers of Conjugate Vaccines Table 19. Global Anti-Infective Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Anti-Infective Vaccines Sales by Type (2021-2026) & (k units) Table 21. Global Anti-Infective Vaccines Sales by Type (2027-2032) & (k units) Table 22. Global Anti-Infective Vaccines Sales Market Share by Type (2021-2026) Table 23. Global Anti-Infective Vaccines Sales Market Share by Type (2027-2032) Table 24. Global Anti-Infective Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Anti-Infective Vaccines Revenue by Type (2021-2026) & (k units) Table 26. Global Anti-Infective Vaccines Revenue by Type (2027-2032) & (k units) Table 27. Global Anti-Infective Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Anti-Infective Vaccines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Bacterial Diseases Table 30. Major Manufacturers of Viral Diseases Table 31. Global Anti-Infective Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Anti-Infective Vaccines Sales by Application (2021-2026) & (k units) Table 33. Global Anti-Infective Vaccines Sales by Application (2027-2032) & (k units) Table 34. Global Anti-Infective Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Anti-Infective Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Anti-Infective Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Anti-Infective Vaccines Revenue by Application (2021-2026) & (k units) Table 38. Global Anti-Infective Vaccines Revenue by Application (2027-2032) & (k units) Table 39. Global Anti-Infective Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Anti-Infective Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Anti-Infective Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Anti-Infective Vaccines Sales by Region (2021-2026) & (k units) Table 43. Global Anti-Infective Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Anti-Infective Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Anti-Infective Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 48. North America Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 49. Europe Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 51. Europe Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Anti-Infective Vaccines Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Anti-Infective Vaccines Sales by Country (2027-2032) & (k units) Table 58. Global Anti-Infective Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Anti-Infective Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Anti-Infective Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Anti-Infective Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Anti-Infective Vaccines Revenue Market Share by Region (2027-2032) Table 63. Sanofi Pasteur Company Information Table 64. Sanofi Pasteur Business Overview Table 65. Sanofi Pasteur Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Pasteur Anti-Infective Vaccines Product Portfolio Table 67. Sanofi Pasteur Recent Development Table 68. Novartis Vaccines Company Information Table 69. Novartis Vaccines Business Overview Table 70. Novartis Vaccines Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Vaccines Anti-Infective Vaccines Product Portfolio Table 72. Novartis Vaccines Recent Development Table 73. Merck & Co. Company Information Table 74. Merck & Co. Business Overview Table 75. Merck & Co. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck & Co. Anti-Infective Vaccines Product Portfolio Table 77. Merck & Co. Recent Development Table 78. GlaxoSmithKline Biologicals Company Information Table 79. GlaxoSmithKline Biologicals Business Overview Table 80. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio Table 82. GlaxoSmithKline Biologicals Recent Development Table 83. Wyeth Pharmaceuticals, Inc. Company Information Table 84. Wyeth Pharmaceuticals, Inc. Business Overview Table 85. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio Table 87. Wyeth Pharmaceuticals, Inc. Recent Development Table 88. Protein Sciences Co. Company Information Table 89. Protein Sciences Co. Business Overview Table 90. Protein Sciences Co. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Protein Sciences Co. Anti-Infective Vaccines Product Portfolio Table 92. Protein Sciences Co. Recent Development Table 93. Organon Teknika Co. Company Information Table 94. Organon Teknika Co. Business Overview Table 95. Organon Teknika Co. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Organon Teknika Co. Anti-Infective Vaccines Product Portfolio Table 97. Organon Teknika Co. Recent Development Table 98. MedImmune LLC Company Information Table 99. MedImmune LLC Business Overview Table 100. MedImmune LLC Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. MedImmune LLC Anti-Infective Vaccines Product Portfolio Table 102. MedImmune LLC Recent Development Table 103. MassBiologics Company Information Table 104. MassBiologics Business Overview Table 105. MassBiologics Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. MassBiologics Anti-Infective Vaccines Product Portfolio Table 107. MassBiologics Recent Development Table 108. Intercell Biomedical Company Information Table 109. Intercell Biomedical Business Overview Table 110. Intercell Biomedical Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Intercell Biomedical Anti-Infective Vaccines Product Portfolio Table 112. Intercell Biomedical Recent Development Table 113. ID Biomedical Co. Company Information Table 114. ID Biomedical Co. Business Overview Table 115. ID Biomedical Co. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. ID Biomedical Co. Anti-Infective Vaccines Product Portfolio Table 117. ID Biomedical Co. Recent Development Table 118. Emergent BioDefense Operations Lansing Inc. Company Information Table 119. Emergent BioDefense Operations Lansing Inc. Business Overview Table 120. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio Table 122. Emergent BioDefense Operations Lansing Inc. Recent Development Table 123. Diagnostics Ltd. Company Information Table 124. Diagnostics Ltd. Business Overview Table 125. Diagnostics Ltd. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio Table 127. Diagnostics Ltd. Recent Development Table 128. CSL Ltd. Company Information Table 129. CSL Ltd. Business Overview Table 130. CSL Ltd. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. CSL Ltd. Anti-Infective Vaccines Product Portfolio Table 132. CSL Ltd. Recent Development Table 133. Berna Biotech Company Information Table 134. Berna Biotech Business Overview Table 135. Berna Biotech Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Berna Biotech Anti-Infective Vaccines Product Portfolio Table 137. Berna Biotech Recent Development Table 138. Barr Labs, Inc. Company Information Table 139. Barr Labs, Inc. Business Overview Table 140. Barr Labs, Inc. Anti-Infective Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio Table 142. Barr Labs, Inc. Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Anti-Infective Vaccines Distributors List Table 146. Anti-Infective Vaccines Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Anti-Infective Vaccines Product Image Figure 2. Global Anti-Infective Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Infective Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Infective Vaccines Sales (2021-2032) & (k units) Figure 5. Global Anti-Infective Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-Infective Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Inactivated Vaccines Image Figure 9. Live/attenuated Vaccines Image Figure 10. Conjugate Vaccines Image Figure 11. Global Anti-Infective Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Anti-Infective Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Anti-Infective Vaccines Sales Market Share by Type (2021-2032) Figure 14. Global Anti-Infective Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Anti-Infective Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Anti-Infective Vaccines Revenue Market Share by Type (2021-2032) Figure 17. Bacterial Diseases Image Figure 18. Viral Diseases Image Figure 19. Global Anti-Infective Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Anti-Infective Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Anti-Infective Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Anti-Infective Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Anti-Infective Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Anti-Infective Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Anti-Infective Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Anti-Infective Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Anti-Infective Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Anti-Infective Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Anti-Infective Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Anti-Infective Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Anti-Infective Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-Infective Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Anti-Infective Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccines
  • Live/attenuated Vaccines
  • Conjugate Vaccines
Applications
  • Bacterial Diseases
  • Viral Diseases
Companies covered
  • Sanofi Pasteur
  • Novartis Vaccines
  • Merck & Co.
  • GlaxoSmithKline Biologicals
  • Wyeth Pharmaceuticals, Inc.
  • Protein Sciences Co.
  • Organon Teknika Co.
  • MedImmune LLC
  • MassBiologics
  • Intercell Biomedical
  • ID Biomedical Co.
  • Emergent BioDefense Operations Lansing Inc.
  • Diagnostics Ltd.
  • CSL Ltd.
  • Berna Biotech
  • Barr Labs, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Infective Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Infective Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-Infective Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-Infective Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-Infective Vaccines Market Dynamics
  1. 2.1 Anti-Infective Vaccines Industry Trends
  2. 2.2 Anti-Infective Vaccines Industry Drivers
  3. 2.3 Anti-Infective Vaccines Industry Opportunities and Challenges
  4. 2.4 Anti-Infective Vaccines Industry Restraints
3 Anti-Infective Vaccines Market by Manufacturers
  1. 3.1 Global Anti-Infective Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-Infective Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-Infective Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-Infective Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Infective Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-Infective Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Anti-Infective Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Infective Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Infective Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Infective Vaccines Tier 1, Tier 2, and Tier 3
4 Anti-Infective Vaccines Market by Type
  1. 4.1 Anti-Infective Vaccines Type Introduction
  2. 4.1.1 Inactivated Vaccines
  3. 4.1.2 Live/attenuated Vaccines
  4. 4.1.3 Conjugate Vaccines
  5. 4.2 Global Anti-Infective Vaccines Sales by Type
  6. 4.2.1 Global Anti-Infective Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anti-Infective Vaccines Sales by Type (2021-2032)
  8. 4.2.3 Global Anti-Infective Vaccines Sales Market Share by Type (2021-2032)
  9. 4.3 Global Anti-Infective Vaccines Revenue by Type
  10. 4.3.1 Global Anti-Infective Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Anti-Infective Vaccines Revenue by Type (2021-2032)
  12. 4.3.3 Global Anti-Infective Vaccines Revenue Market Share by Type (2021-2032)
5 Anti-Infective Vaccines Market by Application
  1. 5.1 Anti-Infective Vaccines Application Introduction
  2. 5.1.1 Bacterial Diseases
  3. 5.1.2 Viral Diseases
  4. 5.2 Global Anti-Infective Vaccines Sales by Application
  5. 5.2.1 Global Anti-Infective Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anti-Infective Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Anti-Infective Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Anti-Infective Vaccines Revenue by Application
  9. 5.3.1 Global Anti-Infective Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anti-Infective Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Anti-Infective Vaccines Revenue Market Share by Application (2021-2032)
6 Global Anti-Infective Vaccines Sales by Region
  1. 6.1 Global Anti-Infective Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Infective Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-Infective Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-Infective Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-Infective Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-Infective Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-Infective Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-Infective Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-Infective Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-Infective Vaccines Revenue by Region
  1. 7.1 Global Anti-Infective Vaccines Revenue by Region
  2. 7.1.1 Global Anti-Infective Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-Infective Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-Infective Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-Infective Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-Infective Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-Infective Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-Infective Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-Infective Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-Infective Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur
  2. 8.1.1 Sanofi Pasteur Company Information
  3. 8.1.2 Sanofi Pasteur Business Overview
  4. 8.1.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur Anti-Infective Vaccines Product Portfolio
  6. 8.1.5 Sanofi Pasteur Recent Developments
  7. 8.2 Novartis Vaccines
  8. 8.2.1 Novartis Vaccines Company Information
  9. 8.2.2 Novartis Vaccines Business Overview
  10. 8.2.3 Novartis Vaccines Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Vaccines Anti-Infective Vaccines Product Portfolio
  12. 8.2.5 Novartis Vaccines Recent Developments
  13. 8.3 Merck & Co.
  14. 8.3.1 Merck & Co. Company Information
  15. 8.3.2 Merck & Co. Business Overview
  16. 8.3.3 Merck & Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co. Anti-Infective Vaccines Product Portfolio
  18. 8.3.5 Merck & Co. Recent Developments
  19. 8.4 GlaxoSmithKline Biologicals
  20. 8.4.1 GlaxoSmithKline Biologicals Company Information
  21. 8.4.2 GlaxoSmithKline Biologicals Business Overview
  22. 8.4.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Portfolio
  24. 8.4.5 GlaxoSmithKline Biologicals Recent Developments
  25. 8.5 Wyeth Pharmaceuticals, Inc.
  26. 8.5.1 Wyeth Pharmaceuticals, Inc. Company Information
  27. 8.5.2 Wyeth Pharmaceuticals, Inc. Business Overview
  28. 8.5.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Portfolio
  30. 8.5.5 Wyeth Pharmaceuticals, Inc. Recent Developments
  31. 8.6 Protein Sciences Co.
  32. 8.6.1 Protein Sciences Co. Company Information
  33. 8.6.2 Protein Sciences Co. Business Overview
  34. 8.6.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Protein Sciences Co. Anti-Infective Vaccines Product Portfolio
  36. 8.6.5 Protein Sciences Co. Recent Developments
  37. 8.7 Organon Teknika Co.
  38. 8.7.1 Organon Teknika Co. Company Information
  39. 8.7.2 Organon Teknika Co. Business Overview
  40. 8.7.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Organon Teknika Co. Anti-Infective Vaccines Product Portfolio
  42. 8.7.5 Organon Teknika Co. Recent Developments
  43. 8.8 MedImmune LLC
  44. 8.8.1 MedImmune LLC Company Information
  45. 8.8.2 MedImmune LLC Business Overview
  46. 8.8.3 MedImmune LLC Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MedImmune LLC Anti-Infective Vaccines Product Portfolio
  48. 8.8.5 MedImmune LLC Recent Developments
  49. 8.9 MassBiologics
  50. 8.9.1 MassBiologics Company Information
  51. 8.9.2 MassBiologics Business Overview
  52. 8.9.3 MassBiologics Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MassBiologics Anti-Infective Vaccines Product Portfolio
  54. 8.9.5 MassBiologics Recent Developments
  55. 8.10 Intercell Biomedical
  56. 8.10.1 Intercell Biomedical Company Information
  57. 8.10.2 Intercell Biomedical Business Overview
  58. 8.10.3 Intercell Biomedical Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Intercell Biomedical Anti-Infective Vaccines Product Portfolio
  60. 8.10.5 Intercell Biomedical Recent Developments
  61. 8.11 ID Biomedical Co.
  62. 8.11.1 ID Biomedical Co. Company Information
  63. 8.11.2 ID Biomedical Co. Business Overview
  64. 8.11.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ID Biomedical Co. Anti-Infective Vaccines Product Portfolio
  66. 8.11.5 ID Biomedical Co. Recent Developments
  67. 8.12 Emergent BioDefense Operations Lansing Inc.
  68. 8.12.1 Emergent BioDefense Operations Lansing Inc. Company Information
  69. 8.12.2 Emergent BioDefense Operations Lansing Inc. Business Overview
  70. 8.12.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Portfolio
  72. 8.12.5 Emergent BioDefense Operations Lansing Inc. Recent Developments
  73. 8.13 Diagnostics Ltd.
  74. 8.13.1 Diagnostics Ltd. Company Information
  75. 8.13.2 Diagnostics Ltd. Business Overview
  76. 8.13.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Diagnostics Ltd. Anti-Infective Vaccines Product Portfolio
  78. 8.13.5 Diagnostics Ltd. Recent Developments
  79. 8.14 CSL Ltd.
  80. 8.14.1 CSL Ltd. Company Information
  81. 8.14.2 CSL Ltd. Business Overview
  82. 8.14.3 CSL Ltd. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CSL Ltd. Anti-Infective Vaccines Product Portfolio
  84. 8.14.5 CSL Ltd. Recent Developments
  85. 8.15 Berna Biotech
  86. 8.15.1 Berna Biotech Company Information
  87. 8.15.2 Berna Biotech Business Overview
  88. 8.15.3 Berna Biotech Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Berna Biotech Anti-Infective Vaccines Product Portfolio
  90. 8.15.5 Berna Biotech Recent Developments
  91. 8.16 Barr Labs, Inc.
  92. 8.16.1 Barr Labs, Inc. Company Information
  93. 8.16.2 Barr Labs, Inc. Business Overview
  94. 8.16.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Barr Labs, Inc. Anti-Infective Vaccines Product Portfolio
  96. 8.16.5 Barr Labs, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-Infective Vaccines Value Chain Analysis
  2. 9.1.1 Anti-Infective Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-Infective Vaccines Production Mode & Process
  6. 9.2 Anti-Infective Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-Infective Vaccines Distributors
  9. 9.2.3 Anti-Infective Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst